Continued Lamivudine Therapy in Patients with Chronic Hepatitis B

Publisher： Karger

E-ISSN： 1423-0100|46|6|377-387

ISSN： 0300-5526

Source： Intervirology, Vol.46, Iss.6, 2003-12, pp. : 377-387

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Feasibility of Discontinuing Lamivudine in Lamivudine-Resistant Chronic Hepatitis B Patients on Lamivudine and Adefovir Combination Therapy

By  

Intervirology, Vol. 57, Iss. 6, 2014-09 ,pp. : 337-343

Karger

Access to resources Recommend Favorite

Short-Term Lamivudine Therapy in Patients with Chronic Hepatitis B

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 362-366

Karger

Access to resources Recommend Favorite

Hepatitis B Genotypes in Chronic Hepatitis B and Lamivudine Therapy

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 373-376

Karger

Access to resources Recommend Favorite

Adefovir and Lamivudine Combination Therapy in Patients with Entecavir-Resistant Chronic Hepatitis B: Antiviral Responses and Evolution of Mutations

By  

Intervirology, Vol. 57, Iss. 5, 2014-06 ,pp. : 239-247

Karger

Access to resources Recommend Favorite

Viral Breakthrough during Lamivudine Therapy for Chronic Hepatitis B

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 344-349

Karger

Access to resources Recommend Favorite